勃林格殷格翰品牌怎么样 申请店铺

我要投票 勃林格殷格翰在兽药行业中的票数:319 更新时间:2025-07-02
勃林格殷格翰是哪个国家的品牌?「勃林格殷格翰」是 上海勃林格殷格翰药业有限公司 旗下著名品牌。该品牌发源于德国,在1885年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力勃林格殷格翰品牌出海!将品牌入驻外推网,定制勃林格殷格翰品牌推广信息,可以显著提高勃林格殷格翰产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

勃林格殷格翰怎么样

兽药十大品牌,始于1885年德国,集人用药品/动物保健/生物制药为一体,致力于人类生物制药化学和动物健康产品研发,专注于生猪/家禽/宠物/牛的疫苗和药品领域


勃林格殷格翰 (Boehringer-Ingelheim)是一家专注人类生物制药化学和动物健康产品的医药公司。包括了处方药和保健消费品。 是世界上颇大的私有制药企业。勃林格殷格翰是一家高度研发驱动的公司,始终专注药品的研究、开发、生产及推广。

勃林格殷格翰的核心业务是人用药品,包括处方药、自主保健品和工业客户业务 (生物制药、药品生产和药用化学品)。勃林格殷格翰出产的药品一直被认为是治疗呼吸、心血管、中枢神经系统疾病及代谢紊乱、传染病的标杆。主要的研究领域包括免疫、肿瘤方面的适应症,目前多个具有治疗价值潜力的活性成分已经研发出来了。

勃林格殷格翰于1994年正式进入中国市场,目前在华投资总额超过2亿欧元,公司管理总部位于上海,业务遍布全国,拥有员工约3500名。勃林格殷格翰中国近年来发展迅速,包括人用药品、动物保健、生物制药3大业务板块并驾齐驱,协调发展,推动公司持续增长。


The top ten brand of veterinary medicine, started in 1885 in Germany, integrates human medicine / animal health care / biopharmaceutical as a whole, devotes to the research and development of human biopharmaceutical chemistry and animal health products, and focuses on the vaccine and drug field of pigs / Poultry / pets / cattle. Boehringer Ingelheim is a pharmaceutical company focusing on human biopharmaceutical chemistry and animal health products. It includes prescription drugs and health care consumer goods. It is a quite large private pharmaceutical enterprise in the world. Boehringer Ingelheim is a highly R & D driven company, which has always focused on the research, development, production and promotion of drugs. The core business of Boehringer Ingelheim is human drugs, including prescription drugs, independent health care products and industrial customer business (biopharmaceutical, pharmaceutical production and pharmaceutical chemicals). The drugs produced by Boehringer Ingelheim have been regarded as the benchmark for the treatment of respiratory, cardiovascular, central nervous system diseases, metabolic disorders and infectious diseases. The main research fields include immune and tumor indications. At present, a number of active ingredients with therapeutic potential have been developed. Boehringer Ingelheim officially entered the Chinese market in 1994. At present, the total investment in China is more than 200 million euros. The company's management headquarters is located in Shanghai, with businesses all over the country and about 3500 employees. In recent years, Boehringer Ingelheim has developed rapidly in China, including three business sectors of human drugs, animal health care and biopharmaceuticals, which are in line with each other, coordinated development and promoted the company's sustained growth.

本文链接: https://brand.waitui.com/a19fcecbe.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

上半年浦东机场入出境外籍人员破500万人次 同比增46%

从上海边检获悉,截至2025年6月30日,上海机场边检站在浦东国际机场口岸累计查验入出境外籍人员突破500万人次,较2024年同期增长46%。(澎湃)

38分钟前

美股大型科技股美股盘前多数下跌,特斯拉跌近6%

36氪获悉,美股大型科技股美股盘前多数下跌,截至发稿,特斯拉跌近6%,英伟达跌超1%,Meta跌0.34%,亚马逊跌0.29%,谷歌跌0.19%,奈飞跌0.17%;苹果涨0.88%,微软涨0.08%。

38分钟前

热门中概股美股盘前多数走弱,京东跌0.77%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,京东跌0.77%,阿里巴巴跌0.63%,拼多多跌0.42%,理想汽车跌0.41%,哔哩哔哩跌0.37%,百度跌0.35%,理想汽车跌0.22%;小鹏汽车涨0.67%,蔚来涨0.3%。

38分钟前

动力新科:全资子公司上汽红岩被申请重整

36氪获悉,动力新科公告,公司全资子公司上汽红岩的债权人重庆安吉物流向重庆五中院申请上汽红岩破产重整。上汽红岩尚未收到债权人的有关告知函,重庆五中院已立案(案号:(2025)渝05破申436号)。上汽红岩为公司重要子公司及重卡业务生产经营平台,若重整成功实施,将有利于化解债务、缓解公司经营压力。但上汽红岩是否被裁定进入重整程序尚存在不确定性,即使进入重整程序,也不代表重整成功。公司将及时披露有关事项的进展情况。

38分钟前

美国财长贝森特预计参议院将于今天下午通过税改法案

美国财政部长斯科特·贝森特预计参议院将于今日下午通过总统特朗普的税收和支出法案。(新浪财经)

38分钟前

本页详细列出关于勃林格殷格翰的品牌信息,含品牌所属公司介绍,勃林格殷格翰所处行业的品牌地位及优势。
咨询